Human Immunodeficiency Virus Type 1 (hiv-1) N-terminal Deleted Gp120 Immunogens

Abstract

The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 7, 2018
  • Application: Jul 5, 2012
    US US 201214130338 A
  • Priority: Jul 5, 2012
    US US 201214130338 A
  • Priority: Jul 5, 2012
    US US 2012/0045530 W
  • Priority: Aug 30, 2011
    US US 201161529137 P
  • Priority: Jul 5, 2011
    US US 201161457906 P

Download Citation


Sign in to the Lens

Feedback